News
Inventors at the NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) are seeking a licensee or collaborator for positive allosteric modulators (PAMs) of the A 3 adenosine receptor (A 3AR), a known therapeutic target. These heterocyclic chemical compounds bind to a lipid

Scientists from the National Institute of Aging (NIA) at National Institutes of Health (NIH) in collaboration with Tawain's National Health Research Institutes and Case Western Reserve University School of Medicine worked with Peptron Inc. a Korean-based public pharmaceutical company to develop a

Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health recently report that genetically modified broadly neutralizing antibodies (bNAbs) protected rhesus macaques from an HIV-like virus. Single infusions of each modified bNAb

Dr. Jorge Munoz will discuss the CDC Trioplex real-time RT-PCR assay for detection and differentiation of Zika, dengue and chikungunya virus infections in one clinical sample. To participate, please pre-register by sending an email to tto@cdc.gov by Thursday, April 26, at 1 p.m. EDT. After